 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/12/2024 |
$3.80 |
$4.05 |
$3.58 |
$3.64 |
22.37M | | 04/15/2024 |
$3.67 |
$3.71 |
$3.40 |
$3.45 |
11.91M | | 04/16/2024 |
$3.45 |
$3.60 |
$3.42 |
$3.58 |
6.44M | | 04/17/2024 |
$3.63 |
$3.80 |
$3.63 |
$3.68 |
9.65M | | 04/18/2024 |
$3.71 |
$3.88 |
$3.64 |
$3.73 |
9.74M |
|
|
| Geron is a biopharmaceutical company that is focused on the development and commercialization of imetelstat, a telomerase inhibitor. Co. is conducting two ongoing Phase 3 clinical trials that are designed to enable registration of imetelstat: (i) IMerge Phase 3 in lower risk myelodysplastic syndromes (MDS), and (ii) IMpactMF in refractory myelofibrosis (MF). Imetelstat has been granted Fast Track designations by the U.S. Food and Drug Administration for the treatment of patients with transfusion-dependent anemia due to lower risk MDS and who are refractory or resistant to treatment with an erythropoiesis stimulating agent and for the treatment of patients with MF. | |
|
Geron (GERN) has the following price history information. Looking back at GERN historical stock prices for the last five trading days, on April 12, 2024, GERN opened at $3.80, traded as high as $4.05 and as low as $3.58, and closed at $3.64. Trading volume was a total of 22.37M shares. On April 15, 2024, GERN opened at $3.67, traded as high as $3.71 and as low as $3.40, and closed at $3.45. Trading volume was a total of 11.91M shares. On April 16, 2024, GERN opened at $3.45, traded as high as $3.60 and as low as $3.42, and closed at $3.58. Trading volume was a total of 6.44M shares. On April 17, 2024, GERN opened at $3.63, traded as high as $3.80 and as low as $3.63, and closed at $3.68. Trading volume was a total of 9.65M shares. On April 18, 2024, GERN opened at $3.71, traded as high as $3.88 and as low as $3.64, and closed at $3.73. Trading volume was a total of 9.74M shares.
GERN Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Geron shares, starting with a $10,000 purchase of GERN, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/22/2014 |
|
| End date: |
04/18/2024 |
|
| Start price/share: |
$2.07 |
|
| End price/share: |
$3.73 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
80.19% |
|
| Average Annual Total Return: |
6.07% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$18,024.18 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/12/2024 | $3.64 | | 04/15/2024 | $3.45 | | 04/16/2024 | $3.58 | | 04/17/2024 | $3.68 | | 04/18/2024 | $3.73 |
|
|
Free GERN Email Alerts:
